US lawmakers object to PTO's control of fees in patent reform bill
This article was originally published in RAJ Devices
Representatives Harold Rogers (Republican - Kentucky), chairman of the House Appropriations Committee, and Paul Ryan (Republican - Wisconsin), chairman of the House Budget Committee, have raised objections to a measure in the patent reform bill introduced in the House in March that would permit the US Patent & Trademark Office to set its own fees1,2.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.